RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. YolTech Therapeutics

YolTech Therapeutics

YolTech Therapeutics is a pioneering gene editing company dedicated to develop a robust gene editing medicines to treat patients with serious diseases, which has built leading high-throughput evolution platform and innovative LNP deliver system.

Latest funding

$45M Series B+ ·

Led by AstraZeneca-CICC Venture Capital · Source: fundraisingfox.com

Funding history ↓
Website: yoltx.com.
X: @yoltech · 2 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology.
Stage: Series B+.
Based in: Minhang, China.
Last round: Sep 11, 2025 · 431 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

X account@yoltech · created Jul 23, 2026 (4 months old) · 2 followers
Website registeredJun 24, 2021 (5 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+$45MAAstraZeneca-CICC Venture Capitalfundraisingfox.com

Timeline

  1. X account created
  2. Website created

Investors

Companies like YolTech Therapeutics

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/yoltech-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy